| Time to send to reviewers | 2 weeks |
|---|---|
| Time to decision with review | 65 days |
| Time to publication | 6 months |
ACTA Pharmaceutica Sciencia
2025 , Vol 63 , Num 1
Bioactivity of hexokinase II inhibitor ikarugamycin and relation with tissue factor in breast cancer cell lines
1 Istanbul Medipol University, Faculty of Medicine, Department of Biochemistry, Istanbul, Türkiye
DOI :
10.23893/1307-2080.APS6312